Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-029-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Sensitisation data (human)
Administrative data
- Endpoint:
- sensitisation data (humans)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Does not include experimental toxicological data
Cross-reference
- Reason / purpose:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 995
Materials and methods
- Study type:
- other: Observational study
Test guideline
- Qualifier:
- no guideline followed
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- Commercial Diisocyanates
Method
- Type of population:
- occupational
- Subjects:
- Cohort = 1780.
Company physicians' case histories of 1780 isocyanate workers of car and chemical companies were evaluated. Specific exposure information is not provided. Sixteen (16) were subjects suspected of having isocyanate-induced hypersensitivity pneumonitis. - Clinical history:
- Not Applicable
- Controls:
- Not Applicable
- Details on study design:
- Chest x-ray films were taken, levels of IgE and IgG antibodies to isocyanate-human serum albumin were estimated; conjugates and isocyanate challenge tests, bronchoalveolar lavage fluid analyses, and/or lung histologic investigations were performed.
Results and discussion
- Results of examinations:
- Each of the 14 study patients who had hypersensitivity pneumonitis had work-related dyspnea and fever occurring several hours after the start of work with isocyanates. Typical clinical findings were the reduction of lung diffusing capacity (n = 10), reticular or nodular lung patterns in the x-ray film (n = 9), and serum IgG antibodies specific to isocyanate- human serum albumin conjugates (n = 10). Restrictive ventilation patterns in the inhalation challenge tests (n 5), lymphocytic and/or neutrophilic alveolitis seen in bronchoalveolar lavage fluid analyses (n = 7), and lymphohistiocytic patterns mostly associated with mild fibrosis in lung histology (n = 5) confirmed the diagnosis.
Any other information on results incl. tables
Hypersensitivity pneumonitis is caused by the inhalation of different organic substances and mediated by cytotoxic mechanisms and various cellular and humoral immune responses. Although the individual pathogenetic role of these responses is not clear, it can be assumed that parameters used diagnostically such as specific IgG antibodies (which may lead to the formation of immune complexes and the activation of the complement cascade) and antigen-specific lymphocyte reactions are also operative in this chronic interstitial lung disease. Symptoms and clinical findings of the 14 cases described here are in line with the generally accepted pathogenesis and diagnostic criteria of hypersensitivity pneumonitis.
Applicant's summary and conclusion
- Conclusions:
- Diisocyanate has been described mainly as causing sensitizing and non-sensitizing asthma, and to a lesser extent hypersensitivity pneumonitis, which is a type of parenchymal lung disease. MDI is the diisocyanate most often implicated. Although the condition is fairly rare, awareness and a sound medical surveillance program are very important so that definite diagnoses of exposed workers can be obtained and appropriate preventive measures can be introduced.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2